These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Author: Hermesh H, Aizenberg D, Weizman A, Lapidot M, Mayor C, Munitz H. Journal: Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693. Abstract: The occurrence of neuroleptic malignant syndrome (NMS) was studied prospectively in two series of consecutive psychiatric in-patients (n = 223). The first group (n = 120) suffered from schizophrenia and was treated only with haloperidol. The second group (n = 103) was treated with diverse neuroleptics. All patients were on a single antipsychotic agent with no anticholinergic drug as prophylaxis. The incidence of full NMS per admission and first neuroleptic exposure was 5/223 (2.2%). Patients with bipolar affective disorder and those treated with injections were significantly over-represented in the NMS group.[Abstract] [Full Text] [Related] [New Search]